Skip to main content

Table 3 Association between maternal second trimester VLDL/Chylomicron (CM) lipoprotein profile and pregnancy outcomes

From: Associations of maternal lipoprotein particle distribution in mid-pregnancy with birth outcomes: a pilot study

Lipid exposure

Birth weight (g) β (95% CI)* N = 25

P-value

Gestational age (weeks) β (95% CI)* N = 25

P-value

Total VLDL/CM particles (nM)

 Model 1

-1.20 (-6.50,4.00)

0.64

-0.002 (-0.02,0.01)

0.80

 Model 2

-1.60 (-6.70,3.50)

0.55

-0.001 (-0.01,0.01)

0.93

Small VLDL/CM particles (nM)

 Model 1

-3.40 (-11.20,4.40)

0.40

-0.014 (-0.03,0.01)

0.17

 Model 2

-4.30 (-12.00,3.30)

0.27

-0.012 (-0.03,0.01)

0.25

Medium VLDL/CM particles (nM)

 Model 1

-2.10 (-12.50,8.40)

0.70

0.017 (-0.01,0.04)

0.24

 Model 2

-1.40 (-11.70,9.00)

0.80

0.014 (-0.01,0.04)

0.30

Large VLDL/CM particles (nM)

 Model 1

48.30 (10.70,85.80)

0.01

0.026 (-0.09,0.14)

0.65

 Model 2

45.80 (5.30,86.20)

0.03

0.070 (-0.04,0.18)

0.22

VLDL/CM size (nm)

 Model 1

25.90 (9.80,42.00)

0.002

0.023 (-0.03,0.07)

0.30

 Model 2

24.90 (8.80,40.90)

0.002

0.029 (-0.02,0.08)

0.23

  1. *Values are beta coefficients (95% CI) derived from linear regression models, representing the change in birth weight (g) or gestational age (weeks) with one increment change in each lipid exposure; Model 1: crude model; Model 2: adjusted for maternal pre-pregnancy BMI
Back to article page

Lipids in Health and Disease

ISSN: 1476-511X